BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $147,000 | +1.4% | 136,000 | +4.6% | 0.02% | -5.0% |
| Q3 2017 | $145,000 | 0.0% | 130,000 | 0.0% | 0.02% | -4.8% |
| Q2 2017 | $145,000 | -2.0% | 130,000 | 0.0% | 0.02% | -4.5% |
| Q1 2017 | $148,000 | -6.9% | 130,000 | -7.8% | 0.02% | -15.4% |
| Q4 2016 | $159,000 | +123.9% | 141,000 | +139.0% | 0.03% | +116.7% |
| Q3 2016 | $71,000 | +14.5% | 59,000 | +5.4% | 0.01% | +9.1% |
| Q2 2016 | $62,000 | -94.3% | 56,000 | -94.0% | 0.01% | -94.7% |
| Q1 2016 | $1,084,000 | -6.6% | 937,000 | +4.2% | 0.21% | -9.5% |
| Q4 2015 | $1,160,000 | +1.0% | 899,000 | +2.4% | 0.23% | -16.3% |
| Q3 2015 | $1,149,000 | -11.1% | 878,000 | +105428.8% | 0.28% | -9.5% |
| Q2 2015 | $1,293,000 | +7.0% | 832 | -99.9% | 0.30% | +1.0% |
| Q1 2015 | $1,208,000 | +44.3% | 818,000 | +115273.8% | 0.30% | +25.8% |
| Q4 2014 | $837,000 | +20.4% | 709 | -99.9% | 0.24% | +19.4% |
| Q3 2014 | $695,000 | -4.1% | 656,000 | -6.3% | 0.20% | -2.9% |
| Q2 2014 | $725,000 | -0.5% | 700,000 | +4.6% | 0.21% | -4.2% |
| Q1 2014 | $729,000 | +21.1% | 669,000 | +18.6% | 0.22% | +16.8% |
| Q4 2013 | $602,000 | – | 564,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|